Efficacy of Concomitant Elemental Diet Therapy in Scheduled Infliximab Therapy in Patients with Crohn’s Disease to Prevent Loss of Response

被引:0
|
作者
Noriko Kamata
Nobuhide Oshitani
Kenji Watanabe
Kimihiko Watanabe
Shuhei Hosomi
Atsushi Noguchi
Tomomi Yukawa
Hirokazu Yamagami
Matsatsugu Shiba
Tetsuya Tanigawa
Toshio Watanabe
Kazunari Tominaga
Yasuhiro Fujiwara
Tetsuo Arakawa
机构
[1] Osaka City University Graduate School of Medicine,Department of Gastroenterology
[2] Aizeznbashi Hospital,Department of Medicine, Social Welfare Service Corporation, Ishii Memorial Aizen
[3] Osaka City General Hospital,en
来源
关键词
Crohn’s disease; Infliximab; Loss of response; Elemental diet;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1382 / 1388
页数:6
相关论文
共 50 条
  • [21] In Patients With Crohn's Disease, Concomitant Enteral Nutrition Reduces the Loss of Response to Adalimumab Maintenance Therapy
    Yoshimura, Naoki
    Kawaguchi, Takaaki
    Sako, Minako
    Saniabadi, Abbi
    Takazoe, Masakazu
    GASTROENTEROLOGY, 2014, 146 (05) : S382 - S382
  • [22] Efficacy of "half elemental diet" as a maintenance therapy for Crohn's disease: Crohn's disease half elemental diet study in Sendai (CHESS): A randomized controlled trial
    Takagi, Sho
    Utsunomiya, Kyoko
    Kuriyama, Shinichi
    Yokoyama, Hiroshi
    Takahashi, Shuichiro
    Iwabuchi, Masahiro
    Takahashi, Hiroki
    Takahashi, Seiichi
    Kinouchi, Yoshitaka
    Hiwatashi, Nobuo
    Funayama, Yuji
    Sasaki, Iwao
    Tsuji, Ichiro
    Shimosegawa, Tooru
    GASTROENTEROLOGY, 2006, 130 (04) : A484 - A484
  • [23] Concomitant Immunomodulator and Infliximab Therapy for Crohn's Disease: A Survey of Physician Practice
    Vajravelu, Ravy
    Katz, Jeffry
    GASTROENTEROLOGY, 2010, 138 (05) : S702 - S702
  • [24] Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series
    Cordero Ruiz, Patricia
    Castro Marquez, Cristina
    Mendez Rufian, Vanesa
    Castro Laria, Luisa
    Caunedo Alvarez, Angel
    Romero Vazquez, Javier
    Herrerias Gutierrez, Juan Manuel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2011, 103 (06) : 294 - 298
  • [25] Efficacy of Enteral Nutrition During Infliximab Maintenance Therapy in Patients with Crohn's Disease
    Yamamoto, Takayuki
    Shiraki, Manabu
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (06) : 1802 - 1803
  • [26] Efficacy of Enteral Nutrition During Infliximab Maintenance Therapy in Patients with Crohn’s Disease
    Takayuki Yamamoto
    Manabu Shiraki
    Digestive Diseases and Sciences, 2013, 58 : 1802 - 1803
  • [27] Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study
    Choi, Chang Hwan
    Do Song, In
    Kim, Young-Ho
    Koo, Ja Seol
    Kim, You Sun
    Kim, Joo Sung
    Kim, Nayoung
    Kim, Eun Soo
    Kim, Jae Hak
    Kim, Ji Won
    Kim, Tae Oh
    Kim, Hyun Soo
    Kim, Hyo Jong
    Park, Young Sook
    Park, Dong Il
    Park, Soo Jung
    Song, Hyun Joo
    Shin, Sung Jae
    Yang, Suk-Kyun
    Ye, Byong Duk
    Lee, Kang-Moon
    Lee, Bo In
    Lee, Sun-Young
    Lee, Chang Kyun
    Im, Jong Pil
    Jang, Byung Ik
    Jeon, Tae Joo
    Cho, Yu Kyung
    Chang, Sae Kyung
    Jeon, Seong Ran
    Jung, Sung-Ae
    Jeen, Yoon Tae
    Cha, Jae Myung
    Han, Dong Soo
    Kim, Won Ho
    YONSEI MEDICAL JOURNAL, 2016, 57 (06) : 1376 - 1385
  • [28] Intensification of infliximab (Ifx) therapy in Crohn's disease:: Efficacy and safety
    Chaparro, Maria
    Martinez-Montiel, P.
    Van Domselaar, Manuel
    Bermejo, Fernando
    Perez-Calle, Jl
    Casis, B.
    Roman, Antonio Lopez-San
    Algaba, Alicia
    Mate-Jimenez, Jose
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2008, 134 (04) : A664 - A664
  • [29] Intensification of Infliximab (IFX) Therapy in Crohn's Disease: Efficacy and Safety
    Chaparro, Maria
    GASTROENTEROLOGY, 2009, 136 (05) : A660 - A660
  • [30] Discontinuation of infliximab in patients with Crohn's disease on combination therapy
    Hindson, Jordan
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (03) : 131 - 131